cell activating factor and is FDA-approved for treating Systemic Lupus Erythematosus (SLE). In this retrospective analysis 16 female SLE patients had been treated with belimumab according to FDA guidelines ... patients…
protease ADAMTS13. In rare cases, TTP may precede the diagnosis of systemic lupus erythematosus (SLE) or occur concurrently. We describe a case of SLE-TTP relapse. Case report ... abdominal pain associated with episodes…
Systemic Lupus Erythematosus (SLE) is a chronic recurrent multisystem autoimmune disorder, which is difficult to diagnose and there is no single diagnostic marker. The cells and tissues undergo damage mediated…
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease and multisystem organ involvement. SLE patients given treatment are manifold, one of which is with steroids. Long time drug administration depends…
Introduction: Systemic Lupus Erythematosus (SLE) is a prototype autoimmune disease with alternating periods of flares and remission. Disease pathogenesis involves vast inflammatory responses, characterized by impaired…
Background: Systemic Lupus Erythematous (SLE) is a prototype autoimmune disease of multifactorial origin mainly assigned to defects in the adaptive immune system. However, evidences supported the crucial role ... work…
This review examines the disease impact on life of 76 SLE patients by collecting data using special questionnaire. The impact of the disease on professional activities has confirmed that ... patients are registered…
study we aim to understand the role of IgG1, IgG2 in Cardiovascular outcomes in SLE and their functions in in-vitro conditions. Methods: We used a unique SLE- Vascular Impact ... Cohort (SLEVIC), which consisted of 116…
well as sequence mutations have been implicated in the pathology of systemic lupus erythematosus (SLE). This study was undertaken to assess the serum DNASE I concentrations and assess the DNASE ... sequence variation in…
Statement of the Problem: Systemic lupus erythematosus (SLE) is a remarkably heterogeneous autoimmune disease. The greatest challenges remain in management of organ damage and lupus nephritis ... most feared phenotypes…
Background: Systemic lupus erythematosus (SLE) is a relatively rare multisystemic autoimmune disorder in the pediatric age group. However, limited data regarding SLE among pediatric cohorts have been published. This…
here are several excellent standardized measures of disease activity and severity in SLE. However, these measures require detailed patient interviews, medical records, and longitudinal follow-up. Population studies of…
Background: Many cases of Systemic lupus erythematosus(SLE) present with hematological manifestations alone, without features of musculoskeletal, skin or other system involvement. The diagnosis may be delayed or…
SLE can present with hematological manifestations alone or along with musculoskeletal, skin or other system involvement. In cases with hematological abnormalities as the predominant or only manifestation, the diagnosis…
Systemic Lupus Erythematosus (SLE) is a chronic, inflammatory, autoimmune, multisystemconnective tissue disease characterized by various autoantibodies to nuclear and cytoplasmic antigens and commonly affects the joints…
laboratory disease parameters. Subjects and Methods: Serum levels of 25(OH)D in 30 SLE without LN (SLE/noLN), 30 SLE with LN (SLE/LN), and 30 matched controls were ... assessed and estimated for deficiency and…
Background: Cardiomyopathy is a rare cardiac complication of SLE and potentially dangerous complication. We are presenting a case of cardiomyopathy in SLE patient as a cardiac complication of SLE. Case…
Objective: Type I diabetes (T1D) and Systemic lupus erythematosus (SLE) are two autoimmune conditions. When occurring in the same patient, they can lead to deleterious end points if not managed ... case of a patient…
positives autoantibody such as ANA, ds DNA, Anti-Sm etc, Therefore, SLE was diagnosed with muti-organs involved including lungs, blood, liver, kidney, medical peritonitis, and central nervous system presented…
Background: Evaluation of antiphospholipid antibodies (aPL) profile in Systemic lupus erythematosus (SLE) patients with obstetric and thrombotic complications and to see the association of different anti phospholipid…
Background and objectives: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that causes damage to many organs of the body. The balance between pro-inflammatory T-helper 17(Th17 ... regulatory-T (Treg)…
APOH as well as TF genes may be associated with systemic lupus erythematosus (SLE) risk and clinical phenotypes in Polish patients. We used a case-control study and examined ... patients with SLE and 552 healthy…
difference of immune cellular compositions in peripheral blood of patients with systemic lupus erythematosus (SLE) and healthy controls. Immune cells in the peripheral blood were obtained from 32 SLE patients ... cells…
Background: Systemic lupus erythematosus (SLE) is a complex, autoimmune disorder with long-term health consequences. Economic evaluation is used by health technology assessment (HTA) bodies to guide drug pricing…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.